RARα shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(3) Regulation of vitamin D receptor expression by retinoic acid receptor alpha in acute myeloid leukemia cellsThe Journal of steroid biochemistry and molecular biologyMay 1, 2016Marchwicka A, Cebrat M, Łaszkiewicz A, Śnieżewski Ł, Brown G, Marcinkowska E.

(4) α-Mangostin, a Natural Agent, Enhances the Response of NRAS Mutant Melanoma to Retinoic AcidMedical science monitor : international medical journal of experimental and clinical researchApril 22, 2016Xia Y, Chen J, Gong C, Chen H, Sun J.

(6) Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D3 in response to disrupted fusion FOP2-FGFR1 gene in acute myeloid leukemia cellsCell & bioscienceJanuary 1, 2016Marchwicka A, Corcoran A, Berkowska K, Marcinkowska E.Carlsbad, CA) was performed as before [22] using control shRNA plasmid-A (sc-108060) or RARA shRNA plasmid (sc-29465-SH; both Santa Cruz). In order to obtain additional control cells, KG1 cells were seeded on 24-well plates

(8) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancerGastroenterologyDecember 1, 2009Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP.

RARα shRNA Plasmid (h)